DOI: 10.1128/AAC.00556-20
Article Information
PubMed
Published By
History
- Published online July 22, 2020.
Copyright & Usage
Copyright © 2020 Venditti et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Article Versions
- Accepted Manuscript version (May 18, 2020).
- You are viewing the most recent version of this article.
Author Information
- Carolina Vendittia,
- Ornella Buteraa,
- Anna Proiab,
- Luigi Rigaccib,
- Bruno Marianic,
- Gabriella Parisic,
- Francesco Messinaa,
- Alessandro Caponed,
- Carla Nisiia and
- Antonino Di Caroa
- aLaboratory of Microbiology, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy
- bHaematology and Haematopoietic Stem Cells Transplant Unit, San Camillo-Forlanini Hospital, Rome, Italy
- cLaboratory of Microbiology and Virology, San Camillo Forlanini Hospital, Rome, Italy
- dSevere and Immunocompromised-associated Infections Unit, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy
- Address correspondence to Carla Nisii, carla.nisii{at}inmi.it.
Citation Venditti C, Butera O, Proia A, Rigacci L, Mariani B, Parisi G, Messina F, Capone A, Nisii C, Di Caro A. 2020. Reduced susceptibility to carbapenems in a Klebsiella pneumoniae clinical isolate producing SCO-1 and CTX-M-15 β-lactamases together with OmpK35 and OmpK36 porin deficiency. Antimicrob Agents Chemother 64:e00556-20. https://doi.org/10.1128/AAC.00556-20.
